Mathieu A.

Mathieu A. is a highly experienced scientist specializing in translational science and biomarker research. Currently serving as a Senior Scientist at NovAliX since July 2023, Mathieu previously held a Senior Scientist position in Biomarker, Translational Research at Galapagos from July 2020 to June 2023. Prior to that, Mathieu worked as a Research Scientist at Immutep Ltd, focusing on the pre-clinical development of an anti-LAG-3 agonist antibody. Matthieu's academic background includes a Post-doctoral Research Fellow position at Institut Pasteur, where research centered around HIV-1 specific CD8+ T cell gene expression, and another post-doctoral role at the Ragon Institute of MGH, MIT and Harvard, studying regulatory T cells and HIV-1 infection. Mathieu holds a Ph.D. in Immunology from Nantes Université and a Master's Degree in cellular and molecular therapies from Université Paris-Est Créteil.